| Issue |
Natl Sci Open
Volume 1, Number 1, 2022
Special Topic: COVID-19: Virus, Immunity and Vaccines
|
|
|---|---|---|
| Article Number | 20220004 | |
| Number of page(s) | 7 | |
| Section | Life Sciences and Medicine | |
| DOI | https://doi.org/10.1360/nso/20220004 | |
| Published online | 25 March 2022 | |
- ESMO. COVID-19 vaccination in cancer patients: ESMO Statements. https://www.esmo.org/covid-19-and-cancer/covid-19-vaccination (4 October 2021, date last accessed). [Google Scholar]
- He Y, Ding Y, Cao B et al. COVID-19 vaccine development from the perspective of cancer patients. Hum Vaccines Immunother 2021; 17 : 3281- 3287. [Article] [CrossRef] [PubMed] [Google Scholar]
- Ribas A, Sengupta R, Locke T et al. Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer Discov 2021; 11 : 233- 236. [Article] [CrossRef] [PubMed] [Google Scholar]
- Wu Z, McGoogan JM Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA 2020; 323 : 1239. [Article] [CrossRef] [PubMed] [Google Scholar]
- Meng Y, Lu W, Guo E et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol 2020; 13 : 75. [Article] [CrossRef] [PubMed] [Google Scholar]
- Wang QQ, Berger NA, Xu R When hematologic malignancies meet COVID-19 in the United States: infections, death and disparities. Blood Rev 2021; 47 : 100775. [Article] [CrossRef] [PubMed] [Google Scholar]
- Rüthrich MM, Giessen-Jung C, Borgmann S et al. COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry. Ann Hematol 2021; 100 : 383- 393. [Article] [CrossRef] [PubMed] [Google Scholar]
- Lee LY, Cazier JB, Angelis V et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020; 395 : 1919- 1926. [Article] [CrossRef] [PubMed] [Google Scholar]
- Dai M, Liu D, Liu M et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov 2020; 10 : 783- 791. [Article] [CrossRef] [PubMed] [Google Scholar]
- Bakouny Z, Paciotti M, Schmidt AL et al. Cancer screening tests and cancer diagnoses during the COVID-19 pandemic. JAMA Oncol 2021; 7 : 458. [Article] [CrossRef] [PubMed] [Google Scholar]
- Garassino MC, Vyas M, de Vries EGE et al. The ESMO call to action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate. Ann Oncol 2021; 32 : 579- 581. [Article] [CrossRef] [PubMed] [Google Scholar]
- Monin L, Laing AG, Muñoz-Ruiz M et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol 2021; 22 : 765- 778. [Article] [CrossRef] [PubMed] [Google Scholar]
- Ligumsky H, Safadi E, Etan T et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine among actively treated cancer patients. J Natl Cancer Inst 2021; 114 : 203- 209. [Article] [Google Scholar]
- So ACP, McGrath H, Ting J et al. COVID-19 vaccine safety in cancer patients: a single centre experience. Cancers 2021; 13 : 3573. [Article] [CrossRef] [PubMed] [Google Scholar]
- Charshafian S, Liang SY Rapid fire: infectious disease emergencies in patients with cancer. Emerg Med Clin N Am 2018; 36 : 493- 516. [Article] [CrossRef] [Google Scholar]
- Recommended Adult Immunization Schedule for ages or older, United States. https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf (2 October 2021, date last accessed). [Google Scholar]
- Recommended Child and Adolescent Immunization Schedule for ages or younger, United States. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf (2 October 2021, date last accessed). [Google Scholar]
- Jia S, Li J, Liu Y et al. Precision immunization: a new trend in human vaccination. Hum Vacc Immunother 2020; 16 : 513- 522. [Article] [CrossRef] [PubMed] [Google Scholar]
- Recommended Adult Immunization Schedule for ages or older, United States. https://www.esmo.org/covid-19-and-cancer/covid-19-vaccination (6 October 2021, date last accessed). [Google Scholar]
- Frenzel E, Chemaly RF, Ariza-Heredia E et al. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control 2016; 44 : 1016- 1021. [Article] [CrossRef] [PubMed] [Google Scholar]
- Gundavda MK, Gundavda KK Cancer or COVID-19? A review of recommendations for COVID-19 vaccination in cancer patients. Curr Treat Options Oncol 2021; 22 : 95. [Article] [CrossRef] [PubMed] [Google Scholar]
- Gauci ML, Coutzac C, Houot R et al. SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC). Eur J Cancer 2021; 148 : 121- 123. [Article] [CrossRef] [PubMed] [Google Scholar]
- CDC. COVID-19 vaccines for moderately or severely immunocompromised people. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html (6 October, date last accessed). [Google Scholar]
- CDC. Data and clinical considerations for additional doses inimmunocompromised people. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-07/07-COVID-Oliver-508.pdf (6 October, date last accessed). [Google Scholar]
- Meerveld-Eggink A, de Weerdt O, van der Velden AMT et al. Response to influenza virus vaccination during chemotherapy in patients with breast cancer. Ann Oncol 2011; 22 : 2031- 2035. [Article] [CrossRef] [PubMed] [Google Scholar]
- McManus M, Frangoul H, McCullers JA et al. Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer 2014; 61 : 815- 820. [Article] [CrossRef] [PubMed] [Google Scholar]
- Doganis D, Kafasi A, Dana H et al. Immune response to influenza vaccination in children with cancer. Hum Vacc Immunother 2018; 14 : 2310- 2317. [Article] [CrossRef] [PubMed] [Google Scholar]
- Berglund A, Willén L, Grödeberg L et al. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and in adult outpatients with ongoing treatment for cancer with and without rituximab. Acta Oncol 2014; 53 : 1212- 1220. [Article] [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
- Cheng FWT, Ip M, Chu YYL et al. Humoral response to conjugate pneumococcal vaccine in paediatric oncology patients. Arch Dis Child 2012; 97 : 358- 360. [Article] [CrossRef] [PubMed] [Google Scholar]
- Provinciali M Immunosenescence and cancer vaccines. Cancer Immunol Immunother 2009; 58 : 1959- 1967. [Article] [CrossRef] [PubMed] [Google Scholar]
- Yancik R, Ries LAG Aging and cancer in America. Hematol Oncol Clin North Am 2000; 14 : 17- 23. [Article] [CrossRef] [PubMed] [Google Scholar]
- Mazzola P, Radhi S, Mirandola L et al. Aging, cancer, and cancer vaccines. Immun Ageing 2012; 9 : 1- 11. [Article] [CrossRef] [PubMed] [Google Scholar]
- Baniyash M Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol 2006; 16 : 80- 88. [Article] [CrossRef] [PubMed] [Google Scholar]
- Ariza-Heredia EJ, Chemaly RF Practical review of immunizations in adult patients with cancer. Hum Vacc Immunother 2015; 11 : 2606- 2614. [Article] [CrossRef] [PubMed] [Google Scholar]
- Kamar N, Abravanel F, Marion O et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med 2021; 385 : 661- 662. [Article] [CrossRef] [PubMed] [Google Scholar]
- Bitterman R, Eliakim-Raz N, Vinograd I et al. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev 2018; 2 : CD008983. [Article] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.